Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7635721B2 · kind B2 · utility
1Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2006 |
| Grant date | Dec 22, 2009 |
| Priority date | — |
| Expiry date | Jul 15, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C231/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Crystalline form III of the compound of formula (I):characterized by its powder X-ray diffraction diagram.Medicinal products containing the same which are useful in the treatment of melatoninergic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.